Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Irinotecan (Camptosar)

2 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCGIP1520

07/21/2015

A Phase 1, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability, and Pharmacokinetic Study of TAS102 in Combination with CPT11 in Patients with Advanced Gastrointestinal Tumors

Treatment

VICCGI14104

06/08/2015

Randomized, Blinded, Multicenter, Phase 2 Study Comparing Veliparib Plus FOLFIRI ? Bevacizumab Versus Placebo Plus FOLFIRI ? Bevacizumab in Previously Untreated Metastatic Colorectal Cancer